XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.20.2

Earnings Per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings per Share | The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Numerator |  |  |  |  |  |  |
Net income (loss) | $ | (59,581) |  |  | $ | (42,308) |  |  | $ | 278,008 |  |  | $ | 12,702 |
Noncontrolling interests' share in earnings | (3,836) |  |  | (3,555) |  |  | (10,839) |  |  | (10,692) |
Net income (loss) attributable to Healthpeak Properties, Inc. | (63,417) |  |  | (45,863) |  |  | 267,169 |  |  | 2,010 |
Less: Participating securities' share in earnings | (351) |  |  | (386) |  |  | (2,151) |  |  | (1,223) |
Net income (loss) applicable to common shares | $ | (63,768) |  |  | $ | (46,249) |  |  | $ | 265,018 |  |  | $ | 787 |
Denominator |  |  |  |  |  |  |
Basic weighted average shares outstanding | 538,333 |  |  | 491,203 |  |  | 527,908 |  |  | 482,595 |
Dilutive potential common shares - equity awards(1) | — |  |  | — |  |  | 279 |  |  | 296 |
Dilutive potential common shares - forward equity agreements(2) | — |  |  | — |  |  | 268 |  |  | 1,901 |
Diluted weighted average common shares | 538,333 |  |  | 491,203 |  |  | 528,455 |  |  | 484,792 |
Earnings (loss) per common share: |  |  |  |  |  |  |
Basic | $ | (0.12) |  |  | $ | (0.09) |  |  | $ | 0.50 |  |  | $ | 0.00 |
Diluted | $ | (0.12) |  |  | $ | (0.09) |  |  | $ | 0.50 |  |  | $ | 0.00 |
_______________________________________ (1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). (2)For the nine months ended September 30, 2020, represents the dilutive impact of 32 million shares that were settled during the nine months then ended. For the nine months ended September 30, 2019, represents the dilutive impact of 11 million shares that were settled during the nine months then ended and 19 million shares of common stock under forward sales agreements that had not been settled as of September 30, 2019. For the three months ended September 30, 2020, forward sales agreements had no dilutive impact as all agreements were settled prior to the start of the period. For the three months ended September 30, 2020 and September 30, 2019, diluted loss per share is calculated using the weighted average common shares outstanding as a result of the Company generating a net loss applicable to common shares for the period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration